ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,868.55
      -0.22%
      US Tech 100
      20,469.04
      0.10%
      Dow Jones
      42,392.27
      -0.36%
      Brent Oil
      75.985
      0.17%
      Bitcoin
      96,682.21
      -0.22%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Telomir Pharmaceuticals Inc (TELO)

      7. Telomir Pharmaceuticals Inc (TELO) Financials

      Telomir Pharmaceuticals Inc

      Telomir Pharmaceuticals Inc (TELO)

      Telenor ASA
      Telenor ASA
      Telenor ASA
      Telenor ASA
      Telo Genomics Corporation
      4.07
      -0.05
      (-1.21%)
      Closed January 02 4:00PM
      Delayed by 15 minutes
      4.09
      0.02
      (0.49%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Telomir Pharmaceuticals Inc Financial Summary

      The current TELO market cap is 120.51M. The company's latest EPS is USD -0.4415 and P/E is -9.26.

      Income Statement

      Annual Quarterly
      Quarter End Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)
      Total Revenue 0000
      Operating Income -1.08M-1.92M-1.47M-5.95M
      Net Income -9.33M-6.26M-1.45M-5.93M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Total Revenue 000
      Operating Income -138k-854k-3.94M
      Net Income -138k-854k-13.07M

      Balance Sheet

      Annual Quarterly
      Quarter End Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)
      Total Assets 4.77M3.5M2.1M1.04M
      Total Liabilities 1.34M486k534k600k
      Total Equity 3.44M3.02M1.57M442k
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Total Assets 049k4.77M
      Total Liabilities 138k986k1.34M
      Total Equity -138k-937k3.44M

      Cash Flow

      Annual Quarterly
      Quarter End Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)
      Operating -3.86M-1.94M-3.46M-4.46M
      Investing N/A N/A N/A N/A
      Financing 3.86M5.21M5.35M5.3M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Operating -119k-469k-3.86M
      Investing N/A N/A N/A
      Financing 119k470k3.86M

      Stats and Ratios

      Market Cap 120.51M
      Price to Earnings Ratio -9.26
      Price to Sales Ratio 0
      Price to Cash Ratio 0
      Price to Book Ratio 35.23
      Dividend Yield -

      Share Statistics

      Shares Outstanding 29.61M
      Average Volume (1 week) 180.69k
      Average Volume (1 Month) 324.52k
      52 Week Change -41.86%
      52 Week High 20.72
      52 Week Low 3.11
      Spread (Intraday) 0.37 (8.33%)

      Company Info

      Company Name Telomir Pharmaceuticals Inc
      Address 900 west platt street, suite 200
      tampa, florida 33606
      Website https://www.telomirpharma.com
      Industry pharmaceutical preparations (2834)

      Your Recent History

      NASDAQ
      TELO
      Telomir Pharmaceuticals
      TG
      A3K8MW
      USA
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads